loading page

Preparing the future of research on deprescribing: results from a survey of early career researchers at the 2nd International Conference on Deprescribing
  • Jérôme Nguyen-Soenen,
  • Thomas Morel,
  • Kristie Weir
Jérôme Nguyen-Soenen
Nantes Universite Departement de Medecine Generale

Corresponding Author:jerome.nguyen-soenen@univ-nantes.fr

Author Profile
Thomas Morel
Nantes Universite Departement de Medecine Generale
Author Profile
Kristie Weir
The University of Sydney School of Public Health
Author Profile

Abstract

Background The deprescribing research field is growing with the recent International Conferences on Deprescribing (ICOD). Early career researchers (ECRs) often face challenges regarding their career development. Objective This study identified ECRs in the deprescribing field, the challenges they face, and potential strategies to support them. Methods An online survey was sent to ECR participants who registered for ICOD2 held in Nantes, France, September 2024. The survey contained 13 questions on demographics, research focus, conference participation, and future directions. A comparison between clinician researchers and full-time researchers identified differences in the challenges they encounter. Results We received a total of 47 (90.4%) responses from 52 participants registered as ECRs. Thirty-four (72.3%) had one or more presentations at the conference. The most common challenges identified by full-time researchers were access to data (7, 33.3%) and funding (7, 33.3%) and for clinician researchers it was time constraints (16, 61.5%), whereas only few (6, 28.6%) full time researchers reported this ( p=0.044). Conclusion While a substantial number of ECRs participated and were engaged at all levels of ICOD2, our survey highlighted that meeting and networking are highly valued. Our findings could provide insights for the development of future ECR initiatives.
27 Dec 2024Submitted to Basic & Clinical Pharmacology & Toxicology
02 Jan 2025Submission Checks Completed
02 Jan 2025Assigned to Editor
02 Jan 2025Review(s) Completed, Editorial Evaluation Pending
07 Jan 2025Reviewer(s) Assigned